Publications by authors named "Arthur Centeno"

Claim this Profile
G
Genetic Modulation of Lifespan: Dynamic Effects, Sex Differences, and Body Weight Trade-offs.
Danny Arends, David G Ashbrook, Suheeta Roy, Lu Lu, Zachary Sloan, Arthur G Centeno

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systems genetics approach delineates the role of Bcl2 in leukemia pathogenesis.
Xinfeng Wang, Akhilesh Kumar Bajpai, Qingqing Gu, Arthur Centeno, Athena Starlard-Davenport

Leuk Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative trait locus mapping identifies a locus linked to striatal dopamine and points to collagen IV alpha-6 chain as a novel regulator of striatal axonal branching in mice.
Mélanie H Thomas, Yujuan Gui, Pierre Garcia, Mona Karout, Borja Gomez Ramos, Arthur Centeno

Genes Brain Behav· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-by-environment modulation of lifespan and weight gain in the murine BXD family.
Suheeta Roy, Maroun Bou Sleiman, Pooja Jha, Jesse F Ingels, Casey J Chapman, Arthur G Centeno

Nat Metab· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A platform for experimental precision medicine: The extended BXD mouse family.
David G Ashbrook, Danny Arends, Pjotr Prins, Megan K Mulligan, Suheeta Roy, Arthur G Centeno

Cell Syst· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards systems genetic analyses in barley: Integration of phenotypic, expression and genotype data into GeneNetwork.
Arnis Druka, Ilze Druka, Arthur G Centeno, Hongqiang Li, Zhaohui Sun

BMC Genet· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer.
Celestia S Higano, John M Corman, David C Smith, Arthur S Centeno, Christopher P Steidle

Cancer· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.
Eric J Small, Natalie Sacks, John Nemunaitis, Walter J Urba, Eugene Dula, Arthur S Centeno

Clin Cancer Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar frequency of testosterone surge after repeat injections of goserelin (Zoladex) 3.6 mg and 10.8 mg: results of a randomized open-label trial.
Norman R Zinner, Mohamed Bidair, Arthur Centeno, Kevin Tomera

Urology· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists.
Michael Koch, Christopher Steidle, Stanley Brosman, Arthur Centeno, Franklin Gaylis

Urology· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis